Literature DB >> 11835420

The risk of lower urinary tract symptoms five years after the first delivery.

Lars Viktrup1.   

Abstract

AIM OF THE STUDY: To estimate the prevalence and 5-year incidence of lower urinary tract symptoms (LUTS) after the first delivery and to evaluate the impact of pregnancy per se and delivery per se on long-lasting symptoms.
MATERIALS AND METHODS: A longitudinal cohort study of 305 primiparae questioned a few days, 3 months, and 5 years after their delivery. The questionnaire used was tested and validated, and the questions were formulated according to the definitions of the International Continence Society (ICS). Maternal, obstetric, and neonatal data concerning every delivery and objective data concerning surgeries during the observation period were obtained from the records. From the sample of 278 women (91%) who responded 5 years after their first delivery, three subpopulations were defined: 1) women without initial LUTS before or during the first pregnancy or during the puerperal period, 2) women with onset of LUTS during the first pregnancy, and 3) women with onset of LUTS during the first puerperium. The risk of LUTS 5 years after the first delivery was examined using bivariate analyses. The obstetric variables in the bivariate tests with a significant association with long-lasting urinary incontinence were entered into a multivariate logistic regression.
RESULTS: The prevalence of stress and urge incontinence 5 years after first delivery was 30% and 15%, respectively, whereas the 5-year incidence was 19% and 11%, respectively. The prevalence of urgency, diurnal frequency, and nocturia 5 years after the first delivery was 18%, 24%, and 2%, respectively, whereas the 5-year incidence was 15%, 20%, and 0.5%, respectively. The prevalence of all LUTS except nocturia increased significantly during the 5 years of observation. The risk of long-lasting stress and urge incontinence was related to the onset and duration of the symptom after the first pregnancy and delivery in a dose-response-like manner. Vacuum extraction at the first delivery was used significantly more often in the group of women with onset of stress incontinence during the first puerperium, whereas an episiotomy at the first delivery was performed significantly more often in the group of women with onset of stress incontinence in the 5 years of observation. The prevalence of urgency and diurnal frequency 5 years after the first delivery was not increased in women with symptom onset during the first pregnancy or puerperium compared with those without such symptoms. The frequency of nocturia 5 years after the first delivery was too low for statistical analysis.
CONCLUSION: The first pregnancy and delivery may result in stress and urge incontinence 5 years later. Women with stress and urge incontinence 3 months after the first delivery have a very high risk of long-lasting symptoms. An episiotomy or a vacuum extraction at the first delivery seems to increase the risk. Subsequent childbearing or surgery seems without significant contribution. Long-lasting urgency, diurnal frequency, or nocturia cannot be predicted from onset during the first pregnancy or puerperium. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11835420     DOI: 10.1002/nau.2198

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  27 in total

1.  Postpartum urinary incontinence.

Authors:  Linda Brubaker
Journal:  BMJ       Date:  2002-05-25

2.  Parity is not associated with urgency with or without urinary incontinence.

Authors:  Annemarie G Hirsch; Vatche A Minassian; Anne Dilley; Jennifer Sartorius; Walter F Stewart
Journal:  Int Urogynecol J       Date:  2010-05-11       Impact factor: 2.894

3.  The effect of vaginal and cesarean delivery on lower urinary tract symptoms: what makes the difference?

Authors:  Henriette Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-21

4.  Electromyographic evaluation of pelvic floor muscles in pregnant and nonpregnant women.

Authors:  Ana Paula Magalhães Resende; Carla Dellabarba Petricelli; Bruno Teixeira Bernardes; Sandra Maria Alexandre; Mary Uchiyama Nakamura; Míriam Raquel Diniz Zanetti
Journal:  Int Urogynecol J       Date:  2012-03-14       Impact factor: 2.894

5.  A study of lower urinary tract symptoms for the Korean women aged 30 and over.

Authors:  Hyo-Jeong Song; Myung-Ja Kim; Jung-Sik Huh; Eun-Ok Park; Eun-Joo Lee; Jung-Sun Moon; Sung-Hee Ahn; Hwan-Cheol Son
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-09-29

6.  Urinary incontinence symptoms during and after pregnancy in continent and incontinent primiparas.

Authors:  Angela D Thomason; Janis M Miller; John Ol Delancey
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-20

7.  Pregnancy and delivery after mid-urethral sling procedures for stress urinary incontinence: case reports and a review of literature.

Authors:  Rian Groenen; M Caroline Vos; Christine Willekes; Harry A M Vervest
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-12-11

8.  Longitudinal comparison study of pelvic floor function between women with and without stress urinary incontinence after vaginal delivery.

Authors:  Mikako Yoshida; Ryoko Murayama; Megumi Haruna; Masayo Matsuzaki; Kenichi Yoshimura; Sachiyo Murashima; Shiro Kozuma
Journal:  J Med Ultrason (2001)       Date:  2012-09-19       Impact factor: 1.314

9.  Mode of delivery and severe stress incontinence. a cross-sectional study among 2,625 perimenopausal women.

Authors:  Xavier Fritel; Virginie Ringa; Noëlle Varnoux; Arnaud Fauconnier; Stéphanie Piault; Gérard Bréart
Journal:  BJOG       Date:  2005-12       Impact factor: 6.531

10.  Association of Delivery Mode With Pelvic Floor Disorders After Childbirth.

Authors:  Joan L Blomquist; Alvaro Muñoz; Megan Carroll; Victoria L Handa
Journal:  JAMA       Date:  2018-12-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.